These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34799214)

  • 1. Combined impact of residual inflammatory risk and chronic kidney disease on long-term clinical outcomes in patients undergoing percutaneous coronary intervention.
    Nishio R; Dohi T; Takeuchi M; Takahashi N; Endo H; Doi S; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
    J Cardiol; 2022 Apr; 79(4):509-514. PubMed ID: 34799214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of C-Reactive Protein on Long-Term Cardiac Events in Stable Coronary Artery Disease Patients with Chronic Kidney Disease.
    Tokuda K; Tanaka A; Tobe A; Shirai Y; Kurobe M; Kubota Y; Kunieda T; Miyazaki T; Mizutani K; Furusawa K; Ishii H; Murohara T
    J Atheroscler Thromb; 2023 Nov; 30(11):1635-1643. PubMed ID: 36908149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual Inflammation Indicated by High-Sensitivity C-Reactive Protein Predicts Worse Long-Term Clinical Outcomes in Japanese Patients after Percutaneous Coronary Intervention.
    Takahashi N; Dohi T; Endo H; Funamizu T; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32268533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions.
    Kalkman DN; Aquino M; Claessen BE; Baber U; Guedeney P; Sorrentino S; Vogel B; de Winter RJ; Sweeny J; Kovacic JC; Shah S; Vijay P; Barman N; Kini A; Sharma S; Dangas GD; Mehran R
    Eur Heart J; 2018 Dec; 39(46):4101-4108. PubMed ID: 30358832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of high-sensitivity C-reactive protein among chronic kidney disease patients undergoing percutaneous coronary intervention.
    Jones D; Spirito A; Sartori S; Smith KF; Pivato CA; Chiarito M; Cao D; Nicolas J; Beerkens F; Edens M; Pileggi B; Sen A; Zhang Z; Vogel B; Sweeny J; Baber U; Dangas G; Sharma SK; Kini A; Mehran R
    J Cardiol; 2023 Sep; 82(3):179-185. PubMed ID: 37187289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention.
    Guedeney P; Claessen BE; Kalkman DN; Aquino M; Sorrentino S; Giustino G; Farhan S; Vogel B; Sartori S; Montalescot G; Sweeny J; Kovacic JC; Krishnan P; Barman N; Dangas G; Kini A; Baber U; Sharma S; Mehran R
    J Am Coll Cardiol; 2019 May; 73(19):2401-2409. PubMed ID: 31097159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent and Combined Effects of Serum Albumin and C-Reactive Protein on Long-Term Outcomes of Patients Undergoing Percutaneous Coronary Intervention.
    Wada H; Dohi T; Miyauchi K; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H
    Circ J; 2017 Aug; 81(9):1293-1300. PubMed ID: 28428450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual Inflammatory Risk and its Association With Events in East Asian Patients After Coronary Intervention.
    Ahn JH; Tantry US; Kang MG; Park HW; Koh JS; Bae JS; Cho SY; Kim KH; Jang JY; Park JR; Park Y; Hwang SJ; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
    JACC Asia; 2022 Jun; 2(3):323-337. PubMed ID: 36338415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
    Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic implications of chronic kidney disease and anemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
    Takeuchi M; Dohi T; Takahashi N; Endo H; Doi S; Kato Y; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Minamino T
    Heart Vessels; 2021 Aug; 36(8):1117-1124. PubMed ID: 33606067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of high-sensitivity C-reactive protein during follow-up on long-term adverse clinical outcomes in patients with coronary artery disease treated with percutaneous coronary intervention.
    Shitara J; Ogita M; Wada H; Tsuboi S; Endo H; Doi S; Konishi H; Naito R; Dohi T; Kasai T; Okazaki S; Isoda K; Suwa S; Miyauchi K; Daida H
    J Cardiol; 2019 Jan; 73(1):45-50. PubMed ID: 30001869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
    Chen H; Spirito A; Sartori S; Nicolas J; Cao D; Zhang Z; Baber U; Kamaleldin K; Guthrie J; Vogel B; Sweeny J; Krishnan P; Sharma SK; Kini A; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2023 Feb; 101(3):511-519. PubMed ID: 36691863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preprocedural high-sensitive C-reactive protein levels on long-term clinical outcomes of patients with stable coronary artery disease and chronic kidney disease who were treated with drug-eluting stents.
    Ogita M; Miyauchi K; Kasai T; Doi S; Wada H; Naito R; Konishi H; Tsuboi S; Dohi T; Tamura H; Okazaki S; Daida H
    J Cardiol; 2015 Jul; 66(1):15-21. PubMed ID: 25572020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic kidney disease on long-term clinical outcomes of everolimus-eluting stent implantation: A subanalysis of the Tokyo-MD PCI registry.
    Miyazaki T; Ashikaga T; Asano M; Sasaoka T; Kurihara K; Yoshikawa S; Isobe M;
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):E9-E16. PubMed ID: 30714680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
    Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
    BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preprocedural High-Sensitivity C-Reactive Protein Predicts Long-Term Outcome of Percutaneous Coronary Intervention.
    Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Hassan A; Okazaki S; Isoda K; Shimada K; Suwa S; Daida H
    Circ J; 2016 Dec; 81(1):90-95. PubMed ID: 27867158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
    Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous Coronary Intervention Does Not Lower Cardiovascular Outcomes in Patients with Chronic Kidney Disease.
    Chernin G; Chen S; Ozan O; Liu M; Haberman D; Perlman G; Ben-Yehuda O; Jonas M
    Am J Nephrol; 2019; 50(6):465-472. PubMed ID: 31655801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of concurrence of metabolic syndrome and chronic kidney disease in patients undergoing coronary intervention: Involvement of coronary plaque composition.
    Kunimura A; Amano T; Uetani T; Harada K; Yoshida T; Suzuki A; Shimbo Y; Kitagawa K; Harada K; Kato B; Kato M; Takashima H; Ando H; Matsubara T; Ishii H; Murohara T
    J Cardiol; 2013 Mar; 61(3):189-95. PubMed ID: 23182943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does clinical profile and outcome differ in patients with Chronic Kidney Disease undergoing percutaneous coronary revascularization according to the severity of CKD? - CHANNEL Study.
    Jayesh M; Kamal S; Riyaz C; Jevin J; Sanjeev B; Krutika P; Sharad J; Jasraj P; Iva P
    Indian Heart J; 2021; 73(4):476-480. PubMed ID: 34474761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.